Efficacy of prophylaxis with low molecular weight heparin in hospitalized oncology patients.
Direct evidence supports the efficacy of low molecular weight heparin in reducing venous thromboembolism risk in hospitalized oncology patients, with a favorable safety profile in terms of major bleeding risk.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5281/zenodo.24344215
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00